XML 24 R7.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE RECOGNITION Revenue Recognition (Notes)
 6 Months Ended
Jun. 30, 2019
Revenue Recognition [Abstract]  
Revenue from Contract with Customer [Text Block] REVENUE

The following table summarizes the disaggregation of revenue by nature:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Dollars in Millions
2019
 
2018
 
2019
 
2018
Net product sales
$
6,031

 
$
5,461

 
$
11,744

 
$
10,433

Alliance revenues
146

 
154

 
275

 
306

Other revenues
96

 
89

 
174

 
158

Total Revenues
$
6,273

 
$
5,704

 
$
12,193

 
$
10,897



The following table summarizes GTN adjustments:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Dollars in Millions
2019
 
2018
 
2019
 
2018
Gross product sales
$
8,819

 
$
7,509

 
$
16,813

 
$
14,210

GTN adjustments(a)
 
 
 
 
 
 
 
Charge-backs and cash discounts
(890
)
 
(663
)
 
(1,664
)
 
(1,246
)
Medicaid and Medicare rebates
(1,090
)
 
(765
)
 
(1,890
)
 
(1,322
)
Other rebates, returns, discounts and adjustments
(808
)
 
(620
)
 
(1,515
)
 
(1,209
)
Total GTN adjustments
(2,788
)
 
(2,048
)
 
(5,069
)
 
(3,777
)
Net product sales
$
6,031

 
$
5,461

 
$
11,744

 
$
10,433


(a)
Includes adjustments to provisions for product sales made in prior periods resulting from changes in estimates of $49 million and $127 million for the three and six months ended June 30, 2019 and $60 million and $110 million for the three and six months ended June 30, 2018, respectively.

The following table summarizes the disaggregation of revenue by product and region:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Dollars in Millions
2019
 
2018
 
2019
 
2018
Prioritized Brands
 
 
 
 
 
 
 
Opdivo
$
1,823

 
$
1,627

 
$
3,624

 
$
3,138

Eliquis
2,042

 
1,650

 
3,967

 
3,156

Orencia
778

 
711

 
1,418

 
1,304

Sprycel
544

 
535

 
1,003

 
973

Yervoy
367

 
315

 
751

 
564

Empliciti
91

 
64

 
174

 
119

 
 
 
 
 
 
 
 
Established Brands

 

 
 
 
 
Baraclude
147

 
179

 
288

 
404

Other Brands
481

 
623

 
968

 
1,239

Total Revenues
$
6,273

 
$
5,704

 
$
12,193

 
$
10,897

 
 
 
 
 
 
 
 
United States
$
3,667

 
$
3,230

 
$
7,116

 
$
6,008

Europe
1,491

 
1,408

 
2,971

 
2,814

Rest of the World
988

 
923

 
1,862

 
1,796

Other(a)
127

 
143

 
244

 
279

Total Revenues
$
6,273

 
$
5,704

 
$
12,193

 
$
10,897


(a)
Other revenues include royalties and alliance-related revenues for products not sold by the Company's regional commercial organizations.
Revenue recognized from performance obligations satisfied in prior periods was $117 million and $264 million for the three and six months ended June 30, 2019 and $150 million and $300 million for the three and six months ended June 30, 2018, respectively, consisting primarily of royalties for out-licensing arrangements and revised estimates for gross-to-net adjustments related to prior period sales. Contract assets were not material at June 30, 2019 and December 31, 2018.